Progesterone and Wegovy: how they interact and what it means for you

You've just been prescribed Wegovy and you're already on progesterone (here's where the question comes from

Most people who raise this concern are either on the progestogen-only pill (the mini-pill, often desogestrel or norethisterone) or on oral progesterone as part of HRT) Utrogestan is a common example. The worry is understandable: you have a hormonal routine that is working, and you do not want a new medicine to disrupt it quietly, without warning.

Wegovy works partly by slowing gastric emptying: food, liquid and oral medicines move through your stomach more slowly than usual. For most medicines this makes little practical difference. For oral hormonal preparations, where consistent absorption timing can affect both contraceptive reliability and symptom control, the question deserves a more careful answer. Our clinical team at nume fields this one regularly.

The NHS England guidance on weight-management injections addresses this directly: it advises that women taking oral contraceptives or oral HRT alongside a GLP-1 medicine should discuss the absorption question with their prescriber. The guidance does not single out progesterone-only preparations specifically, but oral progestogens are oral medicines and the same principle applies. Worth noting that the absorption concern is more firmly documented for tirzepatide (Mounjaro) than for semaglutide; the NHS notes no equivalent evidence of reduced pill effectiveness specifically for semaglutide, though individual variation means the conversation is still important.

If you are also thinking about desogestrel alongside Wegovy, there is a dedicated page covering that combination in more detail.

Oral versus transdermal progesterone: why the route you take it matters more than the hormone itself

The absorption concern with GLP-1 medicines is specifically about the oral route. When progesterone or a progestogen is delivered transdermally (through a skin patch, gel or spray) it enters the bloodstream directly through the skin and completely bypasses the gut. Slowed gastric emptying simply does not affect it.

For women on transdermal progesterone as part of their HRT regimen, this is reassuring: starting Wegovy is unlikely to alter how consistently the hormone reaches your system. For women taking oral progesterone or an oral progestogen-only pill, the picture is less clear-cut, and a prescriber's review of your regimen is the appropriate next step rather than an assumption that everything is fine.

NHS England's guidance on weight-management injections recommends considering transdermal HRT while taking tirzepatide, specifically because of the gut-absorption mechanism. For Wegovy the evidence is less definitive, but the same logic applies if you are on oral HRT and want to manage uncertainty. Any switch from oral to transdermal progesterone is a hormonal decision that should involve the clinician managing your HRT, not something to arrange quietly on the side.

For a broader sense of how semaglutide interacts with the body's hormonal environment, the semaglutide overview page covers the mechanism in plain terms.

Progesterone as HRT: the weight-management angle and what Wegovy can and cannot do

Some women starting HRT in perimenopause find that the hormonal shift comes with weight changes that feel out of their control. Progesterone in particular can cause bloating and fluid retention in some people, which is different from fat gain but feels similar. That context sometimes sits behind the question: people want to know whether Wegovy can work alongside HRT rather than against it.

The short answer is that the two treatments serve different purposes and are not in direct conflict. HRT addresses hormonal deficiency and its symptoms; Wegovy targets weight through appetite and metabolic pathways. There is no evidence that progesterone significantly blunts Wegovy's effect on weight, and Wegovy is not a treatment for HRT side effects. What a prescriber looks at is the full picture: your BMI, your comorbidities, your current medications, and whether any adjustments to your hormonal regimen would make sense before or alongside starting semaglutide.

Wegovy's track record on metabolic markers goes beyond weight alone. If you are curious about whether it has any effect on lipids, the evidence on Wegovy and cholesterol is worth reading before your consultation.

You can also find current Wegovy pricing information if you are at the stage of working out whether private treatment is realistic for you.

Before you start: the conversation to have with a prescriber

The most useful thing you can do before starting Wegovy while on progesterone is to have a single, complete medication review. That means listing every hormonal preparation you take, what form it comes in, and what it is for. A prescriber can then make one of a few recommendations: continue as you are and monitor, switch an oral preparation to a transdermal equivalent, add barrier contraception temporarily if the progestogen is doing contraceptive work, or adjust timing of doses where that is relevant.

None of those decisions should be made on the basis of a web page alone, including this one. Wegovy as a weight-management treatment has a strong evidence base, but it is a prescription medicine and the prescriber's role is precisely to hold all of this context at once.

If you are also wondering about the related question of how semaglutide interacts with testosterone, the semaglutide and testosterone page addresses that separately.

At the end of a long week (or before a holiday when routines shift anyway) it is tempting to put this kind of question off. If you are ready to get a proper clinical view, you can speak to our prescribers through a free consultation. They review every case the same day, and every hormonal medication in your current regimen will be factored in before anything is prescribed.